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Up to one-third of patients with epilepsy are medically intractable and need resective 
surgery. To be successful, epilepsy surgery requires a comprehensive preoperative 
evaluation to define the epileptogenic zone (EZ), the brain area that should be resected 
to achieve seizure freedom. Due to lack of tools and methods that measure the EZ 
directly, this area is defined indirectly based on concordant data from a multitude of 
presurgical non-invasive tests and intracranial recordings. However, the results of these 
tests are often insufficiently concordant or inconclusive. Thus, the presurgical evaluation 
of surgical candidates is frequently challenging or unsuccessful. To improve the efficacy 
of the surgical treatment, there is an overriding need for reliable biomarkers that can 
delineate the EZ. High-frequency oscillations (HFOs) have emerged over the last decade 
as new potential biomarkers for the delineation of the EZ. Multiple studies have shown 
that HFOs are spatially associated with the EZ. Despite the encouraging findings, there 
are still significant challenges for the translation of HFOs as epileptogenic biomarkers 
to the clinical practice. One of the major barriers is the difficulty to detect and localize 
them with non-invasive techniques, such as magnetoencephalography (MEG) or scalp 
electroencephalography (EEG). Although most literature has studied HFOs using invasive 
recordings, recent studies have reported the detection and localization of HFOs using 
MEG or scalp EEG. MEG seems to be particularly advantageous compared to scalp 
EEG due to its inherent advantages of being less affected by skull conductivity and less 
susceptible to contamination from muscular activity. The detection and localization of 
Abbreviations: ECG, electrocardiography; EEG, electroencephalography; EMG, electromyography; EOG, electrooculography; 
EZ, epileptogenic zone; fMRI, functional magnetic resonance imaging; HFO, high-frequency oscillation; IED, interictal epi-
leptiform discharge; iEEG, intracranial electroencephalography; MEG, magnetoencephalography; MEM, maximum entropy 
on the mean; MRE, medically refractory epilepsy; MRI, magnetic resonance imaging; MSI, magnetic source imaging; MUSIC, 
MUltiple SIgnal Classification; PET, positron emission tomography; SAM, synthetic aperture magnetometry; SNR, signal-
to-noise ratio; SOZ, seizure-onset zone; SPECT, single photon emission computed tomography; wMEM, wavelet maximum 
entropy on the mean.
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iNTRODUCTiON
Epilepsy is one of the most common neurological disorders 
affecting children and adults (1, 2). About 65  million people 
currently carry the diagnosis of epilepsy all over the world (3), 
and in the US only, epilepsy causes about $9.6 billion of medical 
expenditures and indirect care (4). Although most of the patients 
are treated successfully with antiepileptic drugs, approximately 
30% of patients suffer from medically refractory epilepsy (MRE), 
i.e., they have unsatisfactory control and continue having seizures 
(5, 6). For these patients, epilepsy surgery represents the most 
promising treatment to pursue seizure freedom.
The objective of epilepsy surgery is the complete resection 
or disconnection of the epileptogenic zone (EZ), the area of 
the cortex necessary for the generation of habitual seizures and 
the smallest amount of tissue that can be removed to achieve a 
seizure-free outcome (7, 8). The only way to evaluate the success 
of the epilepsy surgery is by looking at the postsurgical outcome: 
if the EZ has been correctly identified and resected with no dam-
age to the functionally relevant eloquent cortex (i.e., the region 
that is necessary for defined cortical functions), the patient will 
be seizure free with minimal or no functional deficits. Hence, the 
success of epilepsy surgery strongly depends on the successful 
delineation of the EZ. However, there is no diagnostic modality 
able to unambiguously delineate this zone (8). The EZ is a theo-
retical construct, and to date, there is no established marker that 
definitively determines its location and extent. The EZ can only 
be estimated through a variety of diagnostic tests that point out 
different cortical zones that are considered more or less precise 
indicators of the EZ (8–10) (see Figure 1):
 – The seizure-onset zone (SOZ), i.e., the area where the clinical 
seizures originate on ictal recordings.
 – The irritative zone, i.e., the area of the cortex that generates 
interictal epileptiform discharges (IEDs) in the electroen-
cephalography (EEG) or magnetoencephalography (MEG).
 – The epileptogenic lesion, i.e., a structural brain abnormality 
that is causally related to the epilepsy.
 – The functional deficit zone, i.e., the area of the cortex that 
is functionally abnormal during the interictal period, as 
indicated by neurological examination, neuropsychological 
testing and functional imaging or non-epileptiform EEG or 
MEG abnormalities.
The SOZ is generally considered the best estimate of the EZ, 
and it is removed in the majority of epilepsy surgeries. However, 
the identification of the SOZ is difficult because clinical seizures 
are unpredictable in nature and thus can be difficult to be captured 
by EEG. In addition, seizures captured during patient’s monitor-
ing may not represent the full extent of the EZ. This is why the 
removal of the entire SOZ does not always lead to successful 
outcome. Another indicator of the EZ is the irritative zone, which 
is defined by the localization of IEDs that occur more frequently 
than seizures. The big advantage of the irritative zone is that it 
can be evaluated during the interictal period independently from 
the occurrence of seizures. This reduces the required recording 
time and the associated cost and patient’s discomfort. However, 
the irritative zone is often more widespread than the actual EZ 
and thus less specific to it (9). Furthermore, the presence of an 
epileptogenic lesion in the proximity of the irritative zone or the 
SOZ can provide an additional indicator of the location of the EZ.
Along with the localization of the EZ, the mapping of the 
eloquent cortex is essential to determine viability and strategy 
of the epilepsy surgery. This region is determined during the 
patient’s presurgical evaluation by identifying the essential func-
tional areas that subserve motor, memory, language, and visual 
functions, which need to be preserved from resection. Thus, the 
ultimate goal of epilepsy surgery is to achieve seizure freedom by 
removing the EZ and also avoiding functional deficits caused by 
any damage to the eloquent cortex (10).
All the aforementioned cortical zones are initially defined 
using a battery of non-invasive diagnostic tests, such as scalp 
EEG, MEG, magnetic resonance imaging (MRI), function MRI 
(fMRI), positron emission tomography, and single photon emis-
sion computed tomography. The results of these non-invasive 
tests can be insufficiently concordant and fail to derive a clear 
hypothesis about the location of the EZ. In these cases, long-term 
monitoring with intracranial EEG (iEEG) is needed in order to 
evaluate the possibility of surgery (11–14). However, iEEG record-
ings face several limitations not only related to their invasiveness 
and cost but also to their limited spatial sampling that might lead 
to misleading conclusions (15, 16). The intracranial electrodes 
have a field of view of only several millimeters and, if their place-
ment is not optimal, areas with relevant epileptic activity may be 
overlooked. Therefore, seizures that originate from areas not cov-
ered by the iEEG electrodes, but propagate to the area where the 
electrodes are placed, might lead to misleading results. In order to 
HFOs with MEG would largely expand the clinical utility of these new promising biomark-
ers to an earlier stage in the diagnostic process and to a wider range of patients with 
epilepsy. Here, we conduct a thorough critical review of the recent MEG literature that 
investigates HFOs in patients with epilepsy, summarizing the different methodological 
approaches and the main findings. Our goal is to highlight the emerging potential of MEG 
in the non-invasive detection and localization of HFOs for the presurgical evaluation of 
patients with medically refractory epilepsy (MRE).
Keywords: high-frequency oscillations, magnetoencephalography, epilepsy, epileptogenic zone, epilepsy surgery, 
source localization
FigURe 1 | Schematic representation of the overlapping cortical zones in epilepsy. Different cortical zones are estimated by the epileptologists during the 
presurgical evaluation of a patient with epilepsy. These zones can often overlap, providing the epileptologist with concordant findings for the delineation of the 
epileptogenic zone (EZ). The high-frequency oscillation (HFO) zone is another potentially epileptogenic area that has been recently added to this picture as a further 
piece of information to circumscribe the EZ.
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reduce or improve the use of such invasive, time-consuming, and 
costly investigations, and to improve the postsurgical outcome of 
patients who can undergo surgery, non-invasive presurgical tools 
with high sensitivity and specificity to the epileptogenic focus are 
being sought (17). Utilization of a non-invasive biomarker may 
help in various clinical scenarios that are typical in MRE (18), 
particularly in children. These include, for example, (i) patients 
with early onset severe epilepsies in which both generalized 
clinical semiology and EEG abnormalities can manifest yet with 
the presence of a definitive localized epileptogenic focus (19); (ii) 
tuberous sclerosis with multiple tubers in which resection of the 
most epileptogenic tuber can greatly improve seizure outcome 
(20); (iii) multifocal cortical dysplasia in which resection of the 
most epileptogenic lesion can lead to seizure freedom (21); (iv) 
bilateral migrational anomalies, e.g., polymicrogyria, in which 
partial lesionectomy may lead to seizure control and also enable 
sparing of eloquent cortex; and (v) temporal lobe epilepsy, whose 
large proportion of failed surgeries indirectly shows many under-
lying epileptogenic networks (18).
New Promising Trends for the Delineation 
of the eZ
Given the lack of an unambiguous marker of the EZ and the limi-
tations of the invasive recordings, the presurgical delineation of 
the EZ is complicated and often unsuccessful. As a result, a large 
proportion of patients undergoing epilepsy surgical resection 
[34–73% depending on the resection type (22)] continue to have 
seizures after the surgery. In addition, epilepsy surgery remains 
the most underutilized of all accepted medical interventions 
(23, 24): in United States, less than 1% of patients with MRE are 
referred to epilepsy centers for surgery (25). In order to improve 
the safety and efficacy of the epilepsy surgical treatment, there is 
an overriding need to identify and validate reliable biomarkers 
that can determine the extent and location of the EZ with high 
precision and accuracy.
During the last decade, high-frequency oscillations (HFOs) 
above 80 Hz have emerged as a new promising biomarker of 
epileptogenicity (26, 27). Recent studies have shown that the 
resection of the tissue generating HFOs may improve presurgi-
cal diagnosis (28, 29) and surgical outcome of patients with 
MRE (30–38). The HFO zone has been recently proposed as 
a further piece of information to circumscribe the EZ (see 
Figure  1). Its correlation with the other cortical zones is an 
area of active research (26, 27). Despite the promising findings, 
HFOs are not yet suited for the diagnosis or monitoring of 
epilepsy in clinical practice (39, 40). One of the major reasons 
is the difficulty to detect and localize them with non-invasive 
methods (26, 27, 40). However, as the clinical use of MEG has 
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been increasing for patients with epilepsy (41–47), an emerging 
body of literature has provided evidence that HFOs can be also 
recorded non-invasively (48–52). These recent findings pave 
the way for the translation of these new biomarkers in clinical 
practice.
The use of a non-invasive biomarker of epileptogenicity 
might limit long-term monitoring and invasive intracranial 
recordings leading to a significant improvement of the presur-
gical evaluation procedure in MRE patients. Such a biomarker 
would not only help to identify the epileptogenic tissue for 
surgery but also permit definitive differential diagnosis of epi-
lepsy from acute symptomatic seizures so treatment can begin 
immediately. It might also make it possible to assess the efficacy 
of therapeutic interventions without waiting for another seizure 
to occur, which could be associated with significant morbidity 
or mortality (40).
Meg iN THe PReSURgiCAL evALUATiON 
OF PATieNTS wiTH ePiLePSY
Magnetoencephalography is being increasingly used during the 
first phase of the presurgical evaluation of patients with MRE 
(41–47), helping to evaluate whether surgery is viable and to plan 
the surgical strategy. MEG is rapidly becoming invaluable for the 
presurgical evaluation of patients with epilepsy (17) due to its 
several strengths and possible applications:
•	 Intrinsic properties: MEG presents a unique set of intrinsic 
properties: (i) MEG signals are not distorted by the skull or 
the intervening soft tissues between brain and scalp (53–55); 
this property is particularly important in patients with large 
lesions, anatomical malformations, or patients who already 
had a resection and undergoing second surgery, (ii) MEG, 
unlike EEG, is contactless and thus patient’s preparation is 
faster; this is particularly important for pediatric patients who 
are difficult to stay still for long time and do not always follow 
instructions; (iii) MEG signals can be recorded with a high 
density of sensors avoiding the problem of salt bridge between 
EEG electrodes, a problem often faced particularly in children 
due to their small heads (41); and (iv) high-frequency activity 
is considered to be less susceptible to contamination from 
muscular activity in MEG than in scalp EEG (56, 57).
•	 Functional mapping: MEG has the ability to localize functional 
areas of the brain (58–63), such as primary sensory areas 
(i.e., visual, somatosensory, and auditory cortexes), as well 
as areas responsible for higher and more complex cognitive 
functions [i.e., language (64, 65) and memory (66, 67)]. MEG 
is advantageous compared to alternative methods, such as the 
intraoperative awake surgery (68) and the fMRI (69–71).
•	 Optimization of iEEG: MEG can guide the placement of iEEG 
electrodes (44, 72–74) by providing information regarding 
the localization of epileptic activity and functional areas. Such 
information regarding the electrodes placement is important 
since iEEG cannot be repeated easily due to the local scar 
following implantation. This may be particularly beneficial for 
patients with normal MRI findings (61, 75) or with multifocal/
diffuse disease (45, 76).
In summary, MEG has several significant inherent strengths 
that make it a valuable tool to localize non-invasively the 
epileptic activity, to map the eloquent cortex, and to guide the 
placement of subdural strips and grids and/or depth electrodes. 
The advantages of MEG in the preoperative evaluation of 
patients with MRE have been reported in several studies that 
showed that the concordance of the MEG localization with 
the resected area correlated with postsurgical outcome (61, 
77–79). The major limitation of MEG is the expense: MEG use 
is associated with high costs, first in terms of initial equipment 
purchase (~$1.5–2 million) and second in terms of daily opera-
tions (liquid helium and personnel expertise required) (41). The 
operational costs are expected to decrease significantly in the 
near future thanks to the availability of liquid helium recycling 
systems (41).
BASiC PRiNCiPLeS OF Meg
Magnetoencephalography records the magnetic activity gener-
ated by electrical currents in active neurons of the human brain 
using the phenomenon of electromagnetic induction (41, 80, 
81). Simultaneous recordings of epileptiform activity by MEG 
and iEEG have demonstrated that 4 cm2 of synchronously active 
cortex is needed to generate a spike that can be detected by MEG 
(82). The magnetic signals generated by the human brain are 
extremely weak compared to background electromagnetic activ-
ity. Thus, MEG recordings are performed inside specially designed 
rooms, called magnetically shielded rooms, which minimize the 
electromagnetic noise from external sources such as the power 
line or electrical devices. Figure  2 shows a conventional adult 
MEG system and its basic principles. During MEG recordings, 
the patient lays down on a bed and places his/her head inside 
the MEG sensor helmet. An illustrative complete description of 
MEG recordings can be found elsewhere (51). The MEG helmet 
contains specially designed detection coils that are able to record 
changes in the magnetic field (83, 84). These coils are connected 
to superconducting quantum interference devices, which convert 
the magnetic field passing through the detection coils into voltage 
changes.
Magnetoencephalography offers excellent temporal 
resolution in the range of sub-milliseconds and very good 
spatial resolution of few millimeters (85–89). Under specific 
requirements, MEG can localize superficial sources with an 
accuracy that reaches the cytoarchitectonic level of the cortex 
(90). Several studies reported that MEG and scalp EEG are 
comparable in terms of localization accuracy but their com-
bination has better yield than either technique alone (89, 91). 
In epilepsy patients, some studies showed that MEG is more 
sensitive for spike sources, especially from the neocortex, 
because of the higher signal-to-ratio than EEG (89, 92), but no 
conclusions can be drawn yet. The relative orientation of the 
active source with respect to the skull significantly affects the 
strength of the recorded MEG signals. Sources with tangential 
orientation produce the maximum measurable magnetic field 
outside the scalp, while sources with radial orientation produce 
the minimum measurable magnetic field and thus are almost 
undetectable (93–95).
FigURe 2 | Basic principles of signal generation in a conventional adult magnetoencephalography (Meg) system. (A) A conventional MEG system. The 
patient places his/her head in a special helmet that accommodates a high number of sensors (typically >250). (B) Schematic representation of the electromagnetic 
induction phenomenon: a changing magnetic field (B) generates a measurable electrical current (I) that is recorded outside of the head by special magnetic field 
pick-up coils. The coils are connected with the superconducting quantum interference device (SQUIDs), which convert weak changes in the magnetic field into 
measurable voltage (V). (C) Schematic representation of the MEG signal generation. An intracellular electrical current (blue arrow) generates a magnetic field (red 
ring) around the apical dendrite. The magnetic field is picked up by the detection coils. Sources in the brain sulci cause tangential fields that can be detected by 
MEG.
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MAgNeTiC SOURCe iMAgiNg (MSi)
Magnetoencephalography records the magnetic brain activity that 
is measurable outside the scalp using extracranial sensors. Thus, 
the number, location, and strength of the generators that produce 
the MEG signal are unknown. In order to define the underlying 
generators and estimate their characteristics, the inverse problem 
should be solved (81) (Figure 3). The inverse problem does not 
have unique solution because an infinite number of sources within 
the brain can produce similar extracranially recorded fields. Thus, 
a  priori assumptions about the number and the nature of the 
underlying sources are necessary to constrain the inverse problem 
solution. Assumptions should also be made regarding the nature 
of the volume conductor, what is called the forward problem, by 
postulating a  priori head models (96) (Figure  3). The forward 
problem has unique solution: an intracranial source of known 
location, orientation, and magnitude generates a mathematically 
well-defined extracranial magnetic field.
Magnetic source imaging is the method that combines MEG 
with MRI by projecting the magnetic activity recorded with the 
MEG on the patient’s anatomic image after solving the inverse 
problem (97). The MSI is a model-based imaging technique that 
integrates temporal and spatial components of MEG to identify 
the generating source of the magnetic fields recorded by the physi-
cal MEG sensors (see Figure 3). MSI significantly improves the 
interpretation of MEG raw data, which consist of the magnitudes 
of magnetic fields measured at different recording sites, since it 
enables to estimate the three-dimensional intracerebral location, 
orientation, and time activity of the underlying neuronal sources. 
MSI has both technical and clinical validity in the localization of 
the sources of IEDs (45, 97, 98).
HigH-FReQUeNCY OSCiLLATiONS AS A 
New BiOMARKeR OF ePiLePSY
High-frequency oscillations in epilepsy are generally described 
as short spontaneous EEG patterns in the frequency range from 
80 to 500 Hz, consisting of at least four oscillations that stand 
out of the background activity (27). HFOs can be sub-classified 
according to their frequency content in “ripples” (80–250 Hz) 
and “fast ripples” (250–500  Hz) (99). Recently, very-high-
frequency oscillations (>1,000 Hz) have been also observed in 
patients with epilepsy (100). Ripples and fast ripples seem to be 
generated by different pathophysiological mechanisms, but it 
is still debated whether their relation with the EZ is different. 
FigURe 3 | Magnetic source imaging (MSi): inverse and forward problem. The inverse problem consists in identifying the brain sources (A) that generate the 
observed magnetic field recorded by extracranial magnetoencephalography (MEG) sensors (B). The forward problem explains how a known intracranial source (A) 
produces an extracranial distribution of magnetic activity (B) assuming a specific head model. Flow diagram of the MSI process is shown in (C). MSI with a realistic 
head model requires three inputs: MEG recording, patient’s magnetic resonance imaging (MRI), and digitized coordinates of MEG electrodes.
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In  literature, different recording methodologies (micro- vs. 
macro-electrodes) have been adopted (101), which led to dis-
crepant conclusions (26) on the importance of discriminating 
between the two frequency ranges for the delineation of the EZ. 
Further research is needed to determine whether this discrimi-
nation is crucial or not. Furthermore, it may be challenging to 
reliably distinguish between physiological and pathological 
activity when looking at epileptic HFOs, since they may overlap 
with physiological oscillations in both ripple and fast ripple 
frequency bands (102, 103).
HFOs iN THe PReSURgiCAL evALUATiON 
OF ePiLePSY
High-frequency oscillations are considered a valuable piece of 
information that could enable a direct definition of the EZ (27, 
104) (Figure 1). Recent and ongoing research has been investi-
gating the correlation of the HFO generating area with respect 
to the other cortical zones [for reviews, see Ref. (26, 27, 105, 
106)]. HFOs have proved to be a reliable interictal indicator of 
the SOZ: they have been observed in the SOZ with higher rates 
than outside during interictal periods (107–110). Also, HFOs 
seem to be more specific and accurate markers of the SOZ than 
interictal spikes (110). Interictal HFOs can overlap spikes but can 
also occur independently from them in space and time (109). The 
clinical significance of the distinction between HFOs with and 
without spikes has not been established yet. However, it has been 
suggested that considering only HFOs that overlap with spikes 
would be particularly beneficial in the clinical context because 
it allows (i) reducing the time needed for the inspection of EEG 
or MEG data and (ii) excluding physiological HFOs that would 
represent false detections of epileptogenic biomarkers (111). 
Furthermore, spikes with HFOs have shown to be more closely 
related to the SOZ than spikes in general (109). This has led to 
hypothesize that the presence of HFOs may be crucial to distin-
guish between “red” and “green” spikes, i.e., between pathological 
and non-pathological spikes originating, respectively, from inside 
or outside the EZ. The occurrence of HFOs may help to perform 
such distinction and identify the most epileptogenic spikes (112, 
113). Further research is needed to investigate this HFO-spike 
concurrence in relation to epileptogenicity.
High-frequency oscillations can also help in the delineation of 
the EZ independently of lesional boundaries. HFOs have proved 
to be a more reliable marker of the SOZ than the epileptogenic 
lesion, since their occurrence within a lesion is more closely linked 
to the SOZ than to pathologic tissue changes (114). Furthermore, 
in patients with focal cortical dysplasia, HFOs have been found 
mainly in the SOZ rather than in other areas of pathologic tissue 
(115). Thus, they represent a marker of the SOZ independent of 
the underlying pathology.
Looking at the postsurgical outcome, HFOs have proved to 
be promising markers of epileptogenesis for a successful surgery: 
removal of the HFO generating tissue is an indicator of good 
surgical outcome (31–38), while residual HFOs after surgery can 
predict poor outcome (37). Furthermore, the surgical removal of 
all the HFO generating areas, both within and outside the SOZ, 
correlates with good postsurgical outcome, suggesting that HFOs 
can also point toward epileptogenic areas outside the SOZ (31).
In summary, HFOs seem to be a reliable interictal biomarker 
of tissue capable of generating seizures. However, the evidence 
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for an effective clinical use of HFOs for epilepsy surgery deci-
sion making is still weak (116) and the application of HFOs for 
presurgical evaluation is at an early stage (117, 118). There are 
still significant challenges for the clinical translation of HFOs as 
epileptogenic biomarkers. One of these challenges is the difficulty 
to detect and localize them non-invasively. This is reflected in the 
current literature that mostly investigated HFOs using invasive 
intracranial recordings (26, 27).
HFO Automatic Detection
To date, the visual detection of HFOs has led to a good under-
standing of the relationship between HFOs and epilepsy (26, 27, 
108). However, visual marking is time consuming and subjective, 
since there is not a well-established definition of HFOs that ena-
bles their straightforward identification and each recorded signal 
should be inspected with an extended time scale display (i.e., 
250  mm/s). The development of automatic HFO detectors has 
received much interest during the last decade and represents an 
area of active research (50, 51, 119–129). Such automatic detec-
tors are crucial for the investigation of HFOs as biomarkers of 
epileptogenicity. They are likely necessary to propel future clinical 
applications, since they would enable an objective and consistent 
identification of HFOs in large-scale recordings.
Given the lack of a quantitative definition of HFOs, the cri-
teria used for automated detection differ from study to study, 
as well as the reported range of HFO amplitude (10–1,000 µV) 
and duration (30–100 ms) (120). Several algorithms have been 
proposed in the last decade for the automatic detection of HFOs 
[for reviews, see Ref. (119, 120)]: they commonly define an HFO 
event as characterized by at least four oscillations standing out 
from the ongoing background activity in the frequency range 
of interest (80–500  Hz) and having at least 10  ms inter-event 
interval. In order to distinguish real HFOs from the filtering 
effect of a sharp transient (130) or from other EEG activity, 
recent advances in the automatic detection algorithms have also 
incorporated information from (i) the time–frequency domain, 
assuming that an HFO must appear as a short-lived event with 
an isolated spectral peak at a distinct frequency (51, 122, 128, 
130) (see Figure 4); and (ii) the unfiltered signal, assuming that 
a real HFO must be visible not only in the filtered but also in the 
raw signal (131).
High-Frequency Oscillations and Meg
The non-invasive detection and localization of HFOs with MEG 
would significantly expand the clinical utility of these new prom-
ising biomarkers to an earlier stage in the diagnostic process and 
to a wider range of patients with epilepsy. Some recent studies 
have shown that epileptic HFOs can be detected non-invasively 
with scalp EEG (51, 110, 132–136), MEG (49–52, 137–142), 
or simultaneously with both techniques (51). Figure  4 shows 
simultaneous MEG and scalp EEG data with interictal HFOs co-
occurring with epileptic spikes in a pediatric patient with focal 
epilepsy (51).
Detection of epileptic HFOs with Meg
Given the increasing interest in the non-invasive localization of 
HFOs using MEG, recent studies have proposed novel methods 
for the automatic or semi-automatic detection of HFOs and 
their distinction from artifacts in MEG recordings (49–51). 
MEG data contain more high-frequency artifacts than iEEG 
(143), thus a careful visual inspection of the data is required to 
guarantee that the detected HFOs are indeed of cerebral origin. 
A purely visual HFO detection has been used when a limited 
number of virtual sensors were investigated (49, 52) (more 
details about “virtual” sensors are provided in Section “Non-
Invasive Localization of Epileptic HFOs with MEG”). Yet, given 
the lower rates of HFOs in the MEG data compared to the iEEG 
and the high number of physical sensors (>300), a purely visual 
approach is impractical when analyzing the MEG signals from 
all the physical sensors as in Ref. (50, 51). A semi-automated 
approach for the HFO detection is the most appropriate in these 
cases. This approach consists of a highly sensitive automatic 
detection followed by the visual review of the detected events 
by an EEG/MEG expert in order to increase the specificity of the 
detection method (28, 126, 127, 135).
The automatic detector used in Ref. (50) was designed to iden-
tify HFOs in all the MEG channels and to keep only the events 
occurring in the channel with the highest HFO rate. The proposed 
detector disregarded any HFO that (i) occurred simultaneously in 
more than 100 channels and in different frequency bands, since 
muscle activity and movement artifacts usually involve many 
channels and have a broad frequency content (144); (ii) occurred 
in channels located at the edge of the MEG helmet, since these 
channels are mostly affected by movement (143); or (iii) showed 
a power increase in the ripple band lower than in channels with 
no HFOs. These criteria were proposed to exclude any HFO 
occurring simultaneously with other high-frequency physiologic 
activity, instrumental noise, or artifacts, since they could affect the 
MSI results. Then, the visual review was performed to inspect the 
time–frequency map and to discard artifacts visible in the MEG 
signals in the clinical frequency range (0.3–70 Hz). Limitations 
of the proposed method are possibly due to the subjectivity of 
the time–frequency map inspection, as well as to the lack of con-
sideration of peripheral recordings, such as electrocardiography 
(ECG), electromyography (EMG), or electrooculography (EOG), 
which can help the identification of cardiac, muscular, or ocular 
artifacts (145) resembling HFOs.
Papadelis and colleagues (51) proposed a semi-automatic 
method to identify the HFOs that occurred on both MEG and 
scalp EEG data and that overlapped IEDs. The proposed detector 
identifies HFOs in the EEG signals not only looking at the time 
domain but also verifying the presence of an isolated island in the 
time–frequency map in order to automatically disregard possible 
artifacts (122, 130). Then, the visual review of the detected events 
was performed to keep only the HFOs that are also visible in 
the MEG data and that concur with the IEDs. In addition, to 
exclude any possible artifacts, the authors followed the guidelines 
proposed in Ref. (135) and excluded any oscillation: (i) with 
very high amplitude compared to the background; (ii) showing 
irregular morphology or large frequency variability (as shown 
in Figure 5); or (iii) co-occurring with muscle, movement, and 
electrode artifacts as identified with EOG, ECG, and EMG data 
at the timing of the detected HFOs. The main limitation of the 
proposed detection method is the lack of an automatic HFO 
FigURe 4 | High-frequency oscillations (HFOs) on simultaneous scalp electroencephalography (eeg) and magnetoencephalography (Meg) data. 
(A) Interictal spikes from a pediatric patient (15-year-old girl with encephalomalacia of the right middle cerebral artery region) with medically refractory epilepsy 
simultaneously recorded with scalp EEG (left) and MEG (right). Ten seconds of data filtered from 1 to 70 Hz are shown. (B) Interictal HFOs co-occurring with spikes. 
Extended timescale display of 2 s of data highlighted with gray background in (A). Data are filtered from 80 to 150 Hz for the HFO visualization. HFOs are underlined 
with red lines. (C) Time–frequency map of two representative HFOs marked with black squares in (B). We can observe the isolated peak in the ripple frequency 
band. Source: adapted from Papadelis et al. (51).
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detection in the MEG signals: the EEG/MEG expert should 
verify the presence of simultaneous HFOs in the EEG/MEG 
signals through visual inspection, which can be subjective and 
possibly biased.
Further studies on simultaneous EEG/MEG recordings (51), 
possibly accompanied by simultaneous iEEG as well (135), 
may allow a better understanding of the scalp HFOs. Further 
knowledge and agreement about the morphology and structure 
of the HFOs in MEG data may lead to the design of highly reliable 
detection algorithms. A fully automated approach for the HFO 
detection would enable to analyze large databases minimizing the 
selection bias and human labor.
Non-invasive Localization of epileptic 
HFOs with Meg
Given the high resistivity of the skull and the assumption that a 
large extent of the cortex needs to be active in order to observe 
an HFO on the scalp, HFOs have been mostly investigated with 
intracranial depth electrodes and grids/strips on the cortical 
surface (26, 27, 40, 120). However, a few recent studies reported 
HFOs in the ripple frequency band recorded with scalp EEG in 
patients with epilepsy (51, 110, 132–135), showing lower HFO 
rates than in the iEEG. A recent scalp EEG study also reported 
fast ripples (250–500  Hz) recorded with subdermal electrodes 
in patients with focal epilepsy (136). Given the low number of 
FigURe 5 | High-frequency oscillations (HFOs) vs. artifactual oscillations recorded with scalp electroencephalography (eeg) data from a patient with 
focal epilepsy. (A) Raw EEG with interictal epileptic spikes (gray section). (B) EEG filtered with high-pass filter of 80 Hz. Gray section in (A) is expanded in time and 
amplitude in (B). Ripple HFOs are underlined. The morphology of HFOs is more rhythmic and regular in amplitude and frequency than artifactual oscillations. Source: 
adapted from Andrade-Valenca et al. (110).
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electrodes used, source localization techniques have not been 
used to localize the HFO generators in all these scalp EEG studies, 
except for the one of Papadelis and colleagues (51) who localized 
the HFO sources from high-density scalp EEG data of children 
with MRE. High-density scalp electrode distributions indeed are 
necessary to obtain a solid sampling and accurate localization of 
HFOs on the scalp, as showed by Zelmann and colleagues (135), 
since such oscillations represent the sum of activity of multiple 
spatially distributed focal and coherent sources.
Over the last years, different research studies (48–52, 137–142) 
have focused on the possibility of recording HFOs with MEG and 
localizing their generators at the source level, given the significant 
inherent advantages of MEG compared to scalp EEG. The first 
evidence that HFOs can be non-invasively detected and localized 
using MEG with an accuracy of few millimeters was provided 
by Papadelis et al. (48). In this study, the authors used a head-
shaped construction to generate artificial signals that resemble 
the human HFOs and used MSI with different source methods to 
localize the underlying generators (see Figure 6). Four different 
source localization methods were used: (i) the equivalent cur-
rent dipole (ECD), which describes the underlying source as an 
infinitesimally small line current element (81), was applied at the 
peak activity of HFOs on averaged data; (ii) the MUltiple SIgnal 
Classification (MUSIC), which scans a single ECD through a 
three-dimensional head volume and computes projections onto 
an estimated signal subspace (146); (iii) the synthetic aperture 
magnetometry (SAM), which is a beamformer designed to detect 
signals from a specified location and attenuate signals from all 
other locations (147); and (iv) the magnetic field tomography 
(MFT), which relies on a non-linear algorithm with optimal 
properties for tomographic analysis of the MEG signal (148). 
The authors showed that weak transient signals, resembling the 
human HFOs, can be detected with an accuracy of few millim-
eters at cortical and subcortical regions. All localization methods 
showed high accuracy (localization error <5  mm) even when 
only few (six) trials were included in the analysis. In particular, 
the localization accuracy was unaffected by the low number of 
trials (six) for the beamformer (i.e., the SAM) and the MFT, while 
decreased for the MUSIC and ECD on averaged data. Although 
this study was the first one to provide evidence that human HFOs 
can be non-invasively localized with MEG, it did not report source 
localization data for single events. Epileptic HFOs are non-phase-
locked spontaneous events and their localization analysis must be 
performed on single trials. Furthermore, the confounding effect 
of background activity unrelated to HFOs and its effect on the 
source localization accuracy were not considered.
The source localization of extended generators of oscillatory 
activity in specific frequency bands requires dedicated meth-
odologies. Given the low amplitude and low SNR of HFOs, the 
source localization techniques commonly used for the analysis of 
FigURe 6 | Assessment of magnetoencephalography localization error for high-frequency oscillations (HFOs). Localization error (right panel) for a dipolar 
superficial source (central panel) implanted in a phantom construction (left panel) for different dipole currents (right panel, x-axis) and different source localization 
methods (left panel, different lines): equivalent current dipole on averages (Av-ECD, blue line), MUltiple SIgnal Classification (MUSIC, purple line), synthetic aperture 
magnetometry (SAM, red line), and magnetic field tomography (MFT, green line). The orange bar on the x-axis indicates the current corresponding to human HFOs. 
For details regarding the localization methods, the interested reader should refer to Ref. (48). Source: adapted from Papadelis et al. (48).
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epileptiform discharges with MEG (98, 149) (e.g., the ECD) are 
not recommended for the localization of HFOs (150, 151). This is 
because HFOs are not phase-locked events, and thus, their exact 
onset timing is unknown. As a result, different events cannot be 
averaged before solving the inverse problem to improve the SNR, 
as is typically done in stimulation studies (48, 152) or with epilep-
tic spikes of similar morphology (41). Thus, alternative methods 
optimized for the source localization of single oscillatory events 
are necessary.
To improve the SNR of HFOs, beamforming techniques 
have been used (49, 52). Beamformers have the potential to 
distinguish HFOs from noisy background activity (48, 137, 153). 
The beamformer method (154–156) reconstructs the neuronal 
activity for specific locations within the brain, so-called virtual 
sensors, as the weighed contribution from different MEG physi-
cal sensors. Such beamformer weights act like spatial filters and 
allow attenuating noise from distant sources (154–157). In a 
pioneer work, Van Klink et al. (49) used virtual sensors, whose 
location was defined based on the localization of the interictal 
spikes, in order to improve the SNR of the MEG signals in the 
time domain and to confirm the presence of HFOs (>80  Hz). 
The results of this study showed that the less noisy beamformer 
virtual sensors enabled visual detection of epileptic HFOs that 
could not be identified in the signals recorded by the physical 
MEG sensors (see Figure 7). The HFOs were detected more often 
in the irritative zone than in the contralateral “mirror” region 
and overlapped with other clinical findings. This study showed 
that the proposed non-invasive method enables visual identifi-
cation of areas with epileptic HFOs using MEG. However, this 
study presented a methodological drawback: a limited number 
of virtual sensors were selected based on the location of spikes 
in the physical MEG sensors missing possible HFOs which may 
occur outside the area under investigation. The same approach 
was used by Nissen et  al. (52) to show that brain areas with 
interictal spikes and HFOs were functionally isolated from the 
rest of the interictal epileptic network. The automatic placement 
of a larger number of virtual electrodes, along with automatic 
HFO detection, would make the proposed method more suitable 
for application in clinical setting (52).
Another practical approach for the source localization of 
ripple HFOs in MEG signals was proposed by von Ellenrieder 
et al. (50). This was the first study that detected interictal HFOs 
as visible events standing out from the background MEG signal 
in the time domain and localized their generators at the source 
level. The authors used the wavelet maximum entropy on the 
mean (wMEM) method for the source localization. The wMEM 
is an extension of the maximum entropy on the mean (MEM) 
method (158–160) that is particularly well suited for this appli-
cation since it was developed for the localization of oscillatory 
activity (161). The wMEM decomposes the signal into a discrete 
set of wavelet bases functions; it then performs MEM source 
localization on each time–frequency box (161). The study of von 
Ellenrieder and colleagues (50) is the first one performing MSI 
of spontaneous, and likely pathological, HFOs the ripple band 
(80–160 Hz) in patients with epilepsy. They detected HFOs from 
the signals of the MEG physical sensors, independently of the 
interictal spikes, and used the wMEM method to determine the 
location and extent of their generators on the cortex. For the 
validation of the HFO localization, the authors evaluated the 
spatial concordance of the HFO sources with the epileptogenic 
region defined by two specialists based on the available clinical 
information for each patient (i.e., resected region, ictal and inter-
ictal iEEG findings, visible lesion in the MRI, ictal, and interictal 
scalp EEG findings) (see Figure 8). The validation did not show 
fully concordant results suggesting the need for further studies 
in a larger cohort of patients. Furthermore, such a validation 
approach does not prove that non-invasively localized HFOs 
provide the same results as invasively localized HFOs. To this 
FigURe 7 | High-frequency oscillations (HFOs) on physical magnetoencephalography (Meg) sensors vs. virtual sensors constructed using 
beamforming techniques. Signals from physical MEG sensors (A) over the region where virtual beamformer sensors (B) were placed. Left: signals recorded from 
the irritative zone; right: signals from the mirror zone, i.e., homologous position in the contralateral hemisphere. The data around the interictal spikes (gray section) 
are stretched in time and high pass filtered (>80 Hz) to visualize HFOs. In the irritative zone, the virtual sensors [(B), left] clearly show HFOs (underlined) that are not 
discernable in the physical sensors [(A), left]. Neither spikes nor HFOs are visible in the physical and virtual sensors in the contralateral zone (right). Source: adapted 
from van Klink et al. (49).
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purpose, comparisons of MEG results with the iEEG findings 
from the same subject are necessary to verify that MEG HFO 
localization coincides with the location obtained with invasive 
methods.
The same method for the localization of ripple HFOs was also 
used by Papadelis and colleagues (51) who were the first to inves-
tigate interictal HFOs with simultaneous MEG and high-density 
scalp EEG data from pediatric patients with MRE. In this study, 
the authors identified the HFOs occurring with interictal spikes 
in both MEG and scalp EEG and performed source localization 
using wMEM on the data from both modalities. The results of 
this study showed that the HFO localization was concordant 
between MEG and scalp EEG as well as concordant with other 
clinically relevant zones, such as the irritative zone and the SOZ 
(see Figure 9). The HFO localization for one patient was further 
validated against the ground truth given by the findings obtained 
from the HFOs detected in the iEEG data (see Figure 9, bottom). 
Such validation confirmed the source localization reliability of 
both MEG and scalp EEG. However, given the limited sample 
size, these promising findings need further validation.
In addition to the studies described so far, a series of MEG 
studies investigated the power in high-frequency bands of patients 
with epilepsy using accumulated source imaging (137–142). The 
accumulated source imaging is a source localization method 
that was developed to localize and quantify spontaneous brain 
activity (162). Researchers showed that MEG high-frequency 
components were localized within the EZ in pediatric patients 
with epilepsy (137–142). Xiang and co-workers (139, 140) also 
reported that MEG source localization of ictal and interictal high-
frequency components was concordant with the iEEG results. 
The main limitation of these studies (137–142) is that they did not 
investigate HFOs as individual events in the time domain, as typi-
cally done with iEEG. Thus, it is not possible to establish whether 
the reported high-frequency components have the typical HFO 
morphology in the time domain and if they represent the same 
phenomenon observed in the time domain signals (27, 120, 135).
In summary, evidences from phantom and human studies 
(48–52, 137–141, 143) have shown that human HFOs can be 
non-invasively localized using MEG with an accuracy of few mm. 
Proper methods should be used for their localization because 
HFOs are weak oscillatory transients, which can be otherwise 
undesirably removed if localization methods are applied on 
averaged or coregistered events, as HFOs are not necessarily 
mutually phase locked. To date, there is no MEG study that has 
evaluated the clinical value of the HFO source localization in 
patients with MRE. To this purpose, further studies are needed to 
correlate the localization of the HFO zone with the resected area 
and the postsurgical outcome of patients with MRE. In addition, 
systematic investigations of simultaneous MEG, high-density 
scalp EEG, and iEEG would allow a direct comparison of the two 
FigURe 8 | Output of the detection and localization of high-frequency oscillations (HFOs) with magnetoencephalography (Meg) in three patients 
with focal epilepsy. Upper panels: topographic maps of the HFO detection in the MEG sensors. Each sensor is represented by a dot whose color reflects the 
number of detected HFOs at the time of the HFOs in the highest rate channel. Lower panels: source localization (wavelet maximum entropy on the mean) of HFOs in 
the ripple band for the same three patients. Sources are displayed in a normalized color scale. The epileptogenic zone, determined based on the available clinical 
information, is delineated with a red square. For patient 1 and 2, the sources of HFOs were totally or partially concordant with the epileptogenic region, whereas for 
patient 3, they were discordant. Source: adapted from von Ellenrieder et al. (50).
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non-invasive modalities with the invasive gold standard for an 
optimal validation of the HFO source localization results.
DiSCUSSiON
Significant advances in diagnostic technology have largely 
improved efficacy and safety of epilepsy surgery. Yet, there is still 
an overriding need to identify and validate new reliable biomark-
ers that can precisely delineate the extent and location of the EZ. 
The identification of a more specific biomarker of epileptogenic-
ity would (i) limit the need for long-term monitoring, (ii) enable 
a smaller and more precise resection of the EZ, (iii) improve the 
postsurgical outcome, and (iv) reduce the neurological deficits 
due to excessive surgical resection volume (37). To this purpose, 
HFOs have been the focus of investigations in the last decade 
given their emerging potential as a new precise and reliable bio-
marker of epileptogenicity (26, 27). The possibility to record such 
biomarkers with non-invasive techniques is crucial to expand 
their clinical utility (40). The non-invasiveness of the acquisition 
technique would (i) limit the need for presurgical long-term 
monitoring with iEEG; (ii) enable an optimized planning of 
the intracranial investigations; (iii) allow the assessment of the 
efficacy of therapeutic interventions without waiting for a seizure 
to occur, which can be associated with significant morbidity or 
mortality; (iv) permit definitive differential diagnosis of epilepsy 
from acute symptomatic seizures so treatment can begin imme-
diately; and (v) enable the study of the differentiation between 
physiologic and pathologic HFOs by allowing the non-invasive 
investigation of healthy controls. This strong interest in localizing 
HFOs combined with MEG’s increasing role in the presurgical 
evaluation of patients with MRE (41–47) has led to increasing 
interest in detecting and localizing epileptic HFOs using MEG 
(48–52, 137–142).
In this review, we provided an overview of recent MEG studies 
that investigated HFOs in patients with epilepsy, discussing the 
proposed methodologies and the main findings reported in the 
current literature. The reported results are promising, but also 
foster the need for further MEG studies aiming at: (i) evaluating 
the accuracy of the HFO source localization against a ground 
truth given by simultaneous iEEG recordings in a large sample 
of patients, (ii) evaluating the clinical value of MEG in the HFO 
localization by looking at the patient’s postsurgical outcome and 
its correlation with the resection of the HFO generating areas; 
and (iii) establishing a definition of HFOs that is appropriate for 
FigURe 9 | Spatial concordance between the high-frequency oscillation (HFO) zone localized non-invasively with magnetoencephalography (Meg) 
and high-density scalp electroencephalography (eeg), the irritative zone, and the HFO zone defined invasively with intracranial eeg (ieeg). Upper 
panel: localization of HFOs with scalp EEG (left) and MEG (middle), and localization of interictal epileptiform discharges (IEDs) with MEG (right) overlaid on patient’s 
magnetic resonance imaging (MRI). The HFO source map represents the normalized activation values thresholded at 60% of the maximum activity. Cyan circles and 
bars indicate the locations and orientations of the equivalent current dipoles. The purple triangle indicates the location of averaged dipoles, and the red rectangle the 
location of the dipoles from averaged IEDs. Lower panel: on the left, the localization of HFOs on the iEEG grid is reported (three electrodes with the highest HFO rate 
are highlighted in red on the map of the grid implanted on the patient’s left cortex); on the right, 2 s of data from these three channels with the highest HFO rate are 
shown (LA51, LA52, and LA53). The cortical location corresponding to the electrodes was determined by co-registering the post-implanted computed tomography 
and MRI. Source: from Papadelis et al. (51).
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automatic detection in the context of MEG studies (as this could 
require different criteria compared to the iEEG literature), and 
possibly validating it against the patient’s outcome, rather than 
visual detection (118). Moreover, since high SNR is critical for 
the accurate localization of HFOs (48), the use of virtual channels 
(46, 49) should be further investigated. This will allow the locali-
zation of HFOs without relying on the spike location and avoid-
ing biased results. Source localization could also be improved 
by merging simultaneous scalp EEG and MEG recordings: the 
complementary information of these two modalities might 
improve the source localization reliability (163), in particular for 
the MEM method (164).
CONCLUSiON
The emerging potential of MEG for the detection and localization 
of HFOs in patients with epilepsy has been reported in several 
recent studies. The promising findings emphasize the need for 
large and robust studies necessary to establish and widespread the 
clinical use of HFOs in MEG data as a non-invasive biomarker of 
epileptogenic tissue. The possibility to detect and localize HFOs 
with MEG would open new possibilities of diagnosing and moni-
toring epilepsy. Non-invasively recorded HFOs could provide 
clinicians with an early epileptogenic marker in all patients with 
epilepsy, as well as in patients at high-risk of epilepsy, and could 
be also used to evaluate the effect of antiepileptic drug therapy. 
Finally, further studies are needed to address the question of 
whether the resection of the HFO zone localized with MEG can 
predict the postsurgical outcome of patients with MRE.
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